Literature DB >> 19914228

The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.

Roselia M Spanevello1, Cinthia M Mazzanti, Roberta Schmatz, Gustavo Thomé, Margarete Bagatini, Maisa Correa, Cintia Rosa, Naiara Stefanello, Luziane Potrich Bellé, Maria B Moretto, Liliane Oliveira, Vera M Morsch, Maria R C Schetinger.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a demyelinating neurological disease, which is presumed to be a consequence of infiltrating lymphocytes that are autoreactive to myelin proteins. ATP and adenosine contribute to fine-tuning immune responses and NTPDase (CD39) and adenosine deaminase (ADA) are important enzymes in the control of the extracellular levels of these molecules at the site of inflammation. We evaluated the activity and expression of NTPDase and adenosine deaminase (ADA) activity in lymphocytes from patients with the relapsing-remitting form of MS (RRMS).
METHODS: This study involved 22 patients with RRMS and 22 healthy subjects as a control group. The lymphocytes were isolated from blood and separated on Ficoll density gradients and after isolation the NTPDase and ADA activities were determined.
RESULTS: The NTPDase activity and expression were increased in lymphocytes from RRMS patients when compared with the control group (p<0.05). In addition, a decrease in ADA activity was observed in lymphocytes from these patients when compared to the control group (p<0.05).
CONCLUSIONS: The regulation of ATP and adenosine levels by NTPDase and ADA activities may be important to preserve cellular integrity and to modulate the immune response in MS. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914228     DOI: 10.1016/j.cca.2009.11.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.

Authors:  Jucimara Baldissarelli; Adriana Santi; Roberta Schmatz; Fátima Husein Abdalla; Andréia Machado Cardoso; Caroline Curry Martins; Glaecir R Mundstock Dias; Nicéia Spanholi Calgaroto; Luana Paula Pelinson; Karine Paula Reichert; Vania Lucia Loro; Vera Maria Melchiors Morsch; Maria Rosa Chitolina Schetinger
Journal:  Cell Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.046

Review 2.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

3.  NPP4 is a procoagulant enzyme on the surface of vascular endothelium.

Authors:  Ronald A Albright; William C Chang; Donna Robert; Deborah L Ornstein; Wenxiang Cao; Lynn Liu; Meredith E Redick; J Isaac Young; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Blood       Date:  2012-09-20       Impact factor: 22.113

4.  Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats.

Authors:  Fátima Husein Abdalla; Andréia Machado Cardoso; Luciane Belmonte Pereira; Roberta Schmatz; Jamile Fabbrin Gonçalves; Naiara Stefanello; Amanda Maino Fiorenza; Jessié Martins Gutierres; Jonas Daci da Silva Serres; Daniela Zanini; Victor Camera Pimentel; Juliano Marchi Vieira; Maria Rosa Chitolina Schetinger; Vera Maria Morsch; Cinthia Melazzo Mazzanti
Journal:  Mol Cell Biochem       Date:  2013-09       Impact factor: 3.396

5.  Naringenin Mitigates Iron-Induced Anxiety-Like Behavioral Impairment, Mitochondrial Dysfunctions, Ectonucleotidases and Acetylcholinesterase Alteration Activities in Rat Hippocampus.

Authors:  Yassine Chtourou; Ahlem Ben Slima; Radhouane Gdoura; Hamadi Fetoui
Journal:  Neurochem Res       Date:  2015-06-07       Impact factor: 3.996

6.  Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.

Authors:  Marek Cieślak; Filip Kukulski; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

7.  Effect of Uncaria tomentosa extract on purinergic enzyme activities in lymphocytes of rats submitted to experimental adjuvant arthritis model.

Authors:  Lívia G Castilhos; João F P Rezer; Jader B Ruchel; Maria Luiza Thorstenberg; Jeandre A dos S Jaques; Josiane B Schlemmer; Pedro H Doleski; Mateus F Rossato; Mariane A da Silva; Emerson André Casalli; Ritiel Corrêa da Cruz; Juliano Ferreira; Margareth L Athayde; Jamile F Gonçalves; Daniela B R Leal
Journal:  BMC Complement Altern Med       Date:  2015-06-20       Impact factor: 3.659

Review 8.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

9.  Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.

Authors:  Nuria Álvarez-Sánchez; Ivan Cruz-Chamorro; María Díaz-Sánchez; Patricia Judith Lardone; Juan Miguel Guerrero; Antonio Carrillo-Vico
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

10.  Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.

Authors:  Yuhua Su; Dahlia Nielsen; Lei Zhu; Kristy Richards; Steven Suter; Matthew Breen; Alison Motsinger-Reif; Jason Osborne
Journal:  Hum Genomics       Date:  2013-01-05       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.